Michael C. Rowbotham

University of California, San Francisco — United States

Medicine · Health Sciences

66h-index23.1kcitations188works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Mechanisms and Treatments(97), Pain Management and Placebo Effect(33), Botulinum Toxin and Related Neurological Disorders(30), Musculoskeletal pain and rehabilitation(26), Pain Management and Opioid Use(26)

Publications185 total

Greater recalled pain and movement-evoked pain are associated with longer 400-meter walk and repeat stair climb time: the Study of Muscle, Mobility and Aging
2024Open Access
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement
Pain·2024· 8 citedOpen Access
Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations
Pain·2023· 23 citedOpen Access
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement
Pain·2023· 23 citedOpen Access
Opioids
2023
Itch and Herpes Zoster
2023
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
Journal of Personalized Medicine·2022· 3 citedOpen Access
Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations
Journal of Pain·2022· 82 citedOpen Access
Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis
Pain·2022· 77 cited
Benefit–risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations
Pain·2021· 13 citedOpen Access
Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations
Pain·2021· 44 citedOpen Access
International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
Pain·2021· 53 citedOpen Access
A year like no other: introduction to a special issue on COVID-19 and pain
PAIN Reports·2021· 4 citedOpen Access
Keep Safe: collaborative practice development and research with people with learning disabilities
Tizard Learning Disability Review·2020· 1 cited
Societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
Pain·2020· 15 citedOpen Access
Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
Pain·2020· 196 citedOpen Access
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations
Pain·2020· 156 citedOpen Access
Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews
Pain·2020· 70 citedOpen Access
The ACTTION–APS–AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions
UNC Libraries·2020Open Access
Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models
Journal of Pain·2020· 17 cited
page 1 of 10Next →

Frequent Co-authors

Karin L. Petersen(11), Robert H. Dworkin(9), Bradley S. Galer(8), Ralf Baron(7), John T. Farrar(7), Dennis C. Turk(7), Howard L. Fields(7), Ian Gilron(6), Srinivasa N. Raja(6), Andrew S.C. Rice(6), Mark S. Wallace(6), Pamela Stitzlein Davies(5), Nathaniel P. Katz(5), Troels S. Jensen(4), Michael P. McDermott(4), Jeffrey Tobias(4), Jørgen B. Dahl(4), Nanna Brix Finnerup(3), Nadine Attal(3), Per Hansson(3)